Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 10,471 | 8,328 | 6,955 | 10,961 | 6,871 |
Operating Income | -10,471 | -8,328 | -6,955 | -10,961 | -6,871 |
Other Income | 977 | 463 | -36 | 27 | 62 |
Pre-tax Income | -9,494 | -7,865 | -6,991 | -10,934 | -6,809 |
Income Tax | N/A | 6 | -1 | 1 | 3 |
Net Income Continuous | -9,494 | -7,871 | -6,990 | -10,935 | -6,812 |
Net Income | $-9,494 | $-7,871 | $-6,990 | $-10,935 | $-6,812 |
EPS Basic Total Ops | -0.31 | -0.27 | -0.20 | -0.40 | -0.26 |
EPS Basic Continuous Ops | -0.31 | -0.27 | -0.20 | -0.40 | -0.26 |
EPS Diluted Total Ops | -0.31 | -0.27 | -0.20 | -0.40 | -0.26 |
EPS Diluted Continuous Ops | -0.31 | -0.27 | -0.20 | -0.40 | -0.26 |
EPS Diluted Before Non-Recurring Items | -0.31 | -0.27 | -0.25 | -0.40 | -0.26 |
EBITDA(a) | $-10,471 | $-8,328 | $-6,955 | $-10,961 | $-6,871 |